Zobrazeno 1 - 10
of 606
pro vyhledávání: '"Fatima, Cardoso"'
Autor:
Fatima Cardoso, Shani Paluch-Shimon, Eva Schumacher-Wulf, Leonor Matos, Karen Gelmon, Matti S. Aapro, Jyoti Bajpai, Carlos H. Barrios, Jonas Bergh, Elizabeth Bergsten-Nordström, Laura Biganzoli, Maria João Cardoso, Lisa A. Carey, Mariana Chavez-MacGregor, Runcie Chidebe, Javier Cortés, Giuseppe Curigliano, Rebecca A. Dent, Nagi S. El Saghir, Alexandru Eniu, Lesley Fallowfield, Prudence A. Francis, Sandra X. Franco Millan, Jenny Gilchrist, Joseph Gligorov, William J. Gradishar, Renate Haidinger, Nadia Harbeck, Xichun Hu, Ranjit Kaur, Belinda Kiely, Sung-Bae Kim, Smruti Koppikar, Marion J.J. Kuper-Hommel, Frédéric E. Lecouvet, Ginny Mason, Shirley A. Mertz, Volkmar Mueller, Claire Myerson, Silvia Neciosup, Birgitte V. Offersen, Shinji Ohno, Olivia Pagani, Ann H. Partridge, Frédérique Penault-Llorca, Aleix Prat, Hope S. Rugo, Elzbieta Senkus, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Daniel A. Vorobiof, Peter Vuylsteke, Theresa Wiseman, Binghe Xu, Alberto Costa, Larry Norton, Eric P. Winer
Publikováno v:
Breast, Vol 76, Iss , Pp 103756- (2024)
This manuscript describes the Advanced Breast Cancer (ABC) international consensus guidelines updated at the last two ABC international consensus conferences (ABC 6 in 2021, virtual, and ABC 7 in 2023, in Lisbon, Portugal), organized by the ABC Globa
Externí odkaz:
https://doaj.org/article/de357938368a491d8c29ea9020d3b42e
Autor:
David Groheux, Sofia C. Vaz, Philip Poortmans, Ritse M. Mann, Gary A. Ulaner, Gary J.R. Cook, Elif Hindié, John Patrick Pilkington Woll, Heather Jacene, Isabel T. Rubio, Marie-Jeanne Vrancken Peeters, Elizabeth H. Dibble, Lioe-Fee de Geus-Oei, Stephanie L. Graff, Fatima Cardoso
Publikováno v:
Breast, Vol 78, Iss , Pp 103806- (2024)
Purpose: The recently released EANM/SNMMI guideline, endorsed by several important clinical and imaging societies in the field of breast cancer (BC) care (ACR, ESSO, ESTRO, EUSOBI/ESR, EUSOMA), emphasized the role of [18F]FDG PET/CT in management of
Externí odkaz:
https://doaj.org/article/44ebf936197f4ec5a652aa9113097367
Autor:
Leonor Vasconcelos de Matos, Marcio Debiasi, Teresa Gantes Padrão, Berta Sousa, Fatima Cardoso
Publikováno v:
Breast, Vol 78, Iss , Pp 103793- (2024)
Introduction: The KEYNOTE-522 (KN-522) trial showed that the addition of pembrolizumab to standard chemotherapy improved pathological complete response (pCR) and event-free survival (EFS) for patients with early triple negative breast cancer (TNBC).
Externí odkaz:
https://doaj.org/article/32ee534a75034f2cb821b54b813de3d6
Autor:
Fernando Valencia, Henry L. Gómez, Silvia P. Neciosup, Ronald Limón, María del Carmen Torrico, Lena Morillas, Roberto Torres, Cesar Sánchez, Ingiborg Araya, Rodolfo Gómez, Ricardo Bruges, Carlos Vargas, Tannia Soria, René Muñoz, Mauricio Riofrío, Marco Gálvez, Rossana Ruiz, Pilar Benites, Fatima Cardoso
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEAs the fifth international consensus on advanced breast cancer (ABC5) established guidelines for the management of this disease, the aim of this article was to present the applicability of the consensus recommendations and to generate knowledg
Externí odkaz:
https://doaj.org/article/8f935d08b2b54564931defe7e73edb47
Autor:
Josephine M.N. Lopes Cardozo, Sherylene E. Veira, Laila Ait Hassou, Aimé Lambert Uwimana, Ivana Božović-Spasojević, Jan Bogaerts, Fatima Cardoso, Marjanka K. Schmidt, Emiel J.T. Rutgers, Coralie Poncet, Caroline A. Drukker
Publikováno v:
Breast, Vol 71, Iss , Pp 143-149 (2023)
Purpose: Tailored recommendation for adjuvant chemotherapy in breast cancer patients is of great importance. This survey assessed agreement among oncologists on risk assessment and chemotherapy recommendation, the impact of adding the 70-gene signatu
Externí odkaz:
https://doaj.org/article/68f1f4a4ff414d15974d53b8922bcb3a
Autor:
Ha-Linh Nguyen, Tatjana Geukens, Marion Maetens, Samuel Aparicio, Ayse Bassez, Ake Borg, Jane Brock, Annegien Broeks, Carlos Caldas, Fatima Cardoso, Maxim De Schepper, Mauro Delorenzi, Caroline A. Drukker, Annuska M. Glas, Andrew R. Green, Edoardo Isnaldi, Jórunn Eyfjörð, Hazem Khout, Stian Knappskog, Savitri Krishnamurthy, Sunil R. Lakhani, Anita Langerod, John W. M. Martens, Amy E. McCart Reed, Leigh Murphy, Stefan Naulaerts, Serena Nik-Zainal, Ines Nevelsteen, Patrick Neven, Martine Piccart, Coralie Poncet, Kevin Punie, Colin Purdie, Emad A. Rakha, Andrea Richardson, Emiel Rutgers, Anne Vincent-Salomon, Peter T. Simpson, Marjanka K. Schmidt, Christos Sotiriou, Paul N. Span, Kiat Tee Benita Tan, Alastair Thompson, Stefania Tommasi, Karen Van Baelen, Marc Van de Vijver, Steven Van Laere, Laura van’t Veer, Giuseppe Viale, Alain Viari, Hanne Vos, Anke T. Witteveen, Hans Wildiers, Giuseppe Floris, Abhishek D. Garg, Ann Smeets, Diether Lambrechts, Elia Biganzoli, François Richard, Christine Desmedt
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Obesity is associated with an increased risk of developing breast cancer (BC) and worse prognosis in BC patients, yet its impact on BC biology remains understudied in humans. This study investigates how the biology of untreated primary BC di
Externí odkaz:
https://doaj.org/article/449fce543ad84736bc9d60953aa2df60
Publikováno v:
Breast, Vol 72, Iss , Pp 103576- (2023)
Breast cancer in men is rare, but a relevant public health issue, yielding a 25% higher risk of mortality comparing to female counterparts. The representation of males in clinical trials has been scarce and treatment decisions are based mainly on ext
Externí odkaz:
https://doaj.org/article/adfd4a7ffa77410c8ad2eb521983eb3c
Autor:
Giuseppe Curigliano, Fatima Cardoso, Michael Gnant, Nadia Harbeck, Judy King, Anne-Vibeke Laenkholm, Frédérique Penault-Llorca, Aleix Prat
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Breast cancer multigene signatures (BCMS) have changed how patients with early-stage breast cancer (eBC) are managed, as they provide prognostic information and can be used to select patients who may avoid adjuvant chemotherapy. Clinical gui
Externí odkaz:
https://doaj.org/article/5ed0911aa89840228a24655eb58b36c3
Publikováno v:
Breast, Vol 66, Iss , Pp 262-271 (2022)
Upon its establishment for the treatment of metastatic breast cancer (mBC), continuing trastuzumab beyond disease progression was an important paradigm shift that became the recommendation by major guidelines. However, data supporting continuation of
Externí odkaz:
https://doaj.org/article/29430a3d39e94a09934c3b340cabaf0c